0001795091-23-000001.txt : 20230111 0001795091-23-000001.hdr.sgml : 20230111 20230110183938 ACCESSION NUMBER: 0001795091-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230111 DATE AS OF CHANGE: 20230110 EFFECTIVENESS DATE: 20230111 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OS THERAPIES Inc CENTRAL INDEX KEY: 0001795091 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 825118368 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-470285 FILM NUMBER: 23522204 BUSINESS ADDRESS: STREET 1: 3412 NORTH ABINGDON STREET CITY: ARLINGTON STATE: VA ZIP: 22207 BUSINESS PHONE: 703-541-9811 MAIL ADDRESS: STREET 1: 3412 NORTH ABINGDON STREET CITY: ARLINGTON STATE: VA ZIP: 22207 D 1 primary_doc.xml X0708 D LIVE 0001795091 OS THERAPIES Inc 15825 Shady Grove Road Suite 135 Rockville MD MARYLAND 20850 410-297-7793 DELAWARE None None Corporation true 2018 Paul Romness 15825 Shady Grove Road Suite 135 Rockville MD MARYLAND 20850 Executive Officer Director President and Chief Executive Officer Christopher Acevedo 15825 Shady Grove Road Suite 135 Rockville MD MARYLAND 20850 Executive Officer Chief Financial Officer Robert Petit 15825 Shady Grove Road Suite 135 Rockville MD MARYLAND 20850 Executive Officer Chief Scientific Officer and Chief Medical Officer Jutta Wanner 15825 Shady Grove Road Suite 135 Rockville MD MARYLAND 20850 Executive Officer Chief Technology Officer Colin Goddard 15825 Shady Grove Road Suite 135 Rockville MD MARYLAND 20850 Director Joacim Borg 15825 Shady Grove Road Suite 135 Rockville MD MARYLAND 20850 Director John Ciccio 15825 Shady Grove Road Suite 135 Rockville MD MARYLAND 20850 Director Theodore Search 15825 Shady Grove Road Suite 135 Rockville MD MARYLAND 20850 Director Other Health Care Decline to Disclose 06b false 2022-11-16 false true true true Convertible promissory notes including underlying Class A common stock issuable upon conversion of such notes. false 50000 Noble Capital Markets, Inc. 15768 None None 405 Lexington Ave. 7th Floor New York NY NEW YORK 10174 All States false 2000000 2000000 0 false 11 0 0 0 false OS THERAPIES Inc /s/ Paul Romness Paul Romness President and Chief Executive Officer 2023-01-10